Innoviz gets Nasdaq bid-price extension to 2027
The Nasdaq notice has no immediate effect on the listing or trading of Innoviz's ordinary shares on The Nasdaq Capital Market.
Rhea-AI Filing Summary
Nasdaq granted Innoviz Technologies Ltd. (INVZ) an additional 180 calendar days, until March 22, 2027, to regain compliance with the $1.00-per-share minimum bid-price requirement. Innoviz did not regain compliance during its initial period, which ended September 21, 2026, after Nasdaq had notified the company that its closing bid price was below $1.00 for 30 consecutive business days.
To regain compliance, the closing bid price must be at least $1.00 for a minimum of 10 consecutive business days before March 22, 2027. Nasdaq said the company meets the market-value-of-publicly-held-shares requirement and other applicable initial listing requirements, except for the bid-price requirement. Innoviz is considering options, including a reverse share split within the range shareholders approved on September 16, 2026. The notice has no immediate effect on the listing or trading of its ordinary shares on The Nasdaq Capital Market.
Positive
- None.
Negative
- INVZ did not regain $1.00 bid-price compliance by September 21, 2026.
Key Figures
Key Terms
minimum bid price requirement regulatory
closing bid price regulatory
continued listing requirement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is the INVZ Nasdaq minimum bid-price compliance deadline?
What does INVZ need to do to regain Nasdaq bid-price compliance?
Why did Nasdaq give Innoviz (INVZ) an additional compliance period?
Will the Nasdaq notice immediately affect INVZ trading?
AI-generated analysis. How Rhea-AI works. Not financial advice.